Inclusive of the Operations of the Behar and Benares Opium Agencies during the year 1870-80 (1881)

(under construction)

Indian Hemp Drugs Commission, Government of India (1895)

Report of the Committee Appointed by the Philippine Commission to Investigate the use of opium and the traffic therein. Bureau of Insular Affairs, War Department, Philippines. USA (1905)

Shanghai, China 1909

Departmental Commission on Morphine and Heroin Addiction, United Kingdom (1926)

Panama Canal Zone Military Investigation, USA (1916/29)

Wickersham Commision Report on Alcohol Prohibition, USA (1930)

The Laguardia Committee Report New York, USA (1944)

WHO Report (limited distribution) 1955

Interdepartmental Committee, Drug Addiction, UK (1961)

Drug Addiction Crime or Disease. Joint Committee of the American Bar Association and the American Medical Association on Narcotic Drugs, Interim and Final Reports, USA, (1961)

Interdepartmental Committee, Drug Addiction, UK, (1965)

Advisory Committee on Drug Dependence, Cannabis, UK (1968)

Report of the National Advisory Commission on Civil Disorders, USA, 1968 (under construction)

Release, Caroline Coon & Rufus Harris UK (1969)

An Incquiry into the Legal History of American Marihuana Prohibition, Bonnie and Whitebread, USA (1970)

A Report to the Congress from the Secretary, Department of Health, Education and Welfare, USA 1971

Report of a WHO Scientific Group, United Nations 1971

Canadian Government Commission of Inquiry into the Non/Medical Use of Drugs, Interim Report, Canada (1972)

Canadian Government Commission of Inquiry into the Non/Medical Use of Drugs, Cannabis Report, Canada (1972)

Consumers Union Report on Licit and Illicit Drugs, Edward M Brecher and the editors of Consumers Reports Magazine, USA (1972)

Dealing with Drug Abuse: A Report to the Ford Foundation by the Drug Abuse Survey Project. USA, (1972)

Marihuana: A Signal of Misunderstanding, National Commission on Marihuana and Drug Abuse (Shafer Commission) USA, 1972

Final report of the commission of inquiry into the non medical use of drugs, Canada 1973

Drug Use in America: Problem in Perspective, National Commission on Marihuana and Drug Abuse (Shafer Commission) USA (1973)

technical papers: The legal system and drug control (available soon)

The Nation's Toughest Drug Law: Evaluating the New York Experience, by the Joint Committee on New York Drug Law Evaluation, of the Association of the Bar of the City of New York, USA, 1977

A Discussion Paper, Canadian Government - Health Protection Branch Department of National Health and Welfare, Canada, (1979)

The Facts about Drug Abuse, USA (1980)

National Research Council of the National Academy of Science, USA 1982

American Bar Association, 1986 USA

Report by the Advisory Council on the Misuse of Drugs, UK (1988)

Report by the Advisory Council on the Misuse of Drugs, UK (1989)

TWENTIETH ANNUAL REPORT OF THE State of California RESEARCH ADVISORY PANEL, USA, 1989

NATIONAL COMMISSION ON ACQUIRED IMMUNE DEFICIENCY SYNDROME, Washington, DC, USA, July 1991

A Wiser Course: Ending Drug Prohibition, A Report of The Special Committee on Drugs and the Law of the Association of the Bar of the City of New York USA June 14, 1994

Commonwealth of Australia 1994 Monograph No. 26

TECHNOLOGIES FOR UNDERSTANDING AND PREVENTING SUBSTANCE ABUSE AND ADDICTION, US Government Office of Technology Assessment, USA October 18, 1994

A Comparative Appraisal of the Health and Psychological Consequences of Alcohol, Cannabis, Nicotine and Opiate Use, Canada, August 28, 1995

Dutch Government Report Continuity and change, Netherlands 1995

Dutch Drug Policy Foundation Report, The Netherlands 1995

A Report on Increasing Illicit Drug Use and National Drug Policy, Senate Committee on the Judiciary Senator Orrin G. Hatch, Utah, Chairma USA 1996

REPORT OF THE PREMIER'S DRUG ADVISORY COUNCIL, Australia 1996

Report and recommendations of the Drug Policy Task Force, USA 1996

Medicinal cannabis Report, UK, 1998

Report on the Risk Assessment of MBDB in the Framework of the Joint Action on New Synthetic Drugs 1998

Cannabis Report, Switzerland (1999)

REPORT OF THE INDEPENDENT INQUIRY INTO THE MISUSE OF DRUGS ACT 1971, Chairman: Viscountess Runciman DBE, UK 1999

Report on the Risk Assessment of 4-MTA in the Framework of the Joint Action on New Synthetic Drugs 1999

EU Doc. 9303 21 December 2001

Jamaica 2001

Canadian Senate Commission (2002)

Report on the risk assessment of ketamine in the framework of the joint action on new synthetic drugs 2002

Report on the risk assessment of GHB in the framework of the joint action on new synthetic drugs, 2002

Report on the risk assessment of PMMA in the framework of the joint action on new synthetic drugs, 2003

Controlling Psychoactive Substances: The Current System and Alternative Models, USA 2005

Government of India, Ministry of Home Affairs 2006

2006 national report to the EMCDDA by the Reitox National Focal Point Turkey

Peter Reuter (RAND) and Franz Trautmann (Trimbos Institute), European Union 2007

A joint assessment of HIV/AIDS Prevention, Treatment and Care in China (2007)

Annual Report on the state of drug related problems in Bulgaria, 2007

Cannabis Policy: Moving beyond stalemate, Beckley Foundation UK 2008

Office of China National Narcotic Control Commission

EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL, 2008

Drugs and HIV in Bangladesh, Bhutan, India, Nepal and Sri Lanka, A Regional Report, 2008

Department of Anti-Smuggling and Organized Crime

Report of the Commission on AIDS in Asia, Crafting an Effective Response, 2008

Report of the Advisory Committee on Drugs Policy, 2009

Harm reduction: evidence, impacts and challenges, European Monitoring Centre for Drugs and Drug Addiction 2010

US Federal Government Data on Cannabis Prohibition

International Centre for Science in Drug Policy 2010

Risk assessment report of a new psychoactive substance: 4-methylmethcathinone (mephedrone) 2010

Confronting a Shared Threat

Council on Foreign Relations, USA, 2011

a demos and uk drug policy commission report on legal highs, 2011

Report of the Global Commission on Drug Policy, 2011